Literature DB >> 2310679

The 5T mouse multiple myeloma model: absence of c-myc oncogene rearrangement in early transplant generations.

J Radl1, Y A Punt, M H van den Enden-Vieveen, P A Bentvelzen, M H Bakkus, T W van den Akker, R Benner.   

Abstract

Consistent chromosomal translocations involving the c-myc cellular oncogene and one of the three immunoglobin loci are typical for human Burkitt's lymphoma, induced mouse plasmacytoma (MPC) and spontaneously arising rat immunocytoma (RIC). Another plasma cell malignancy, multiple myeloma (MM), arising spontaneously in the ageing C57BL/KaLwRij mice, was investigated in order to see whether the MM cells contain c-myc abnormalities of the MPC or RIC type. Rearrangement of the c-myc oncogene was found in the bone marrow cells only in 5T2 MM transplantation line in a mouse of the 24th generation and in none of the seven other MM of the 5T series which were of earlier generations. Since the mouse 5T MM resembles the human MM very closely, including the absence of consistent structural c-myc oncogene abnormalities, it can serve as a useful experimental model for studies on the aetiopathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2310679      PMCID: PMC1971422          DOI: 10.1038/bjc.1990.51

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

Review 1.  The myc oncogene in avian and mammalian carcinogenesis.

Authors:  P J Enrietto
Journal:  Cancer Surv       Date:  1987

2.  Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene.

Authors:  A F Gazdar; H K Oie; I R Kirsch; G F Hollis
Journal:  Blood       Date:  1986-06       Impact factor: 22.113

3.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

4.  Animal model of human disease. Multiple myeloma.

Authors:  J Radl; J W Croese; C Zurcher; M H Van den Enden-Vieveen; A M de Leeuw
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

5.  Plasmacytomas in mice.

Authors:  M Potter
Journal:  Semin Oncol       Date:  1986-09       Impact factor: 4.929

6.  An immunofluorescence procedure for the detection of intracellular immunoglobulins.

Authors:  W Hijmans; H R Schuit; F Klein
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

7.  A rapid single step staining technique for DNA analysis by flow microfluorimetry.

Authors:  I W Taylor
Journal:  J Histochem Cytochem       Date:  1980-09       Impact factor: 2.479

8.  Rapid transfer of DNA from agarose gels to nylon membranes.

Authors:  K C Reed; D A Mann
Journal:  Nucleic Acids Res       Date:  1985-10-25       Impact factor: 16.971

9.  Multiple chromosomal rearrangements in a spontaneously arising t(6;7) rat immunocytoma juxtapose c-myc and immunoglobulin heavy chain sequences.

Authors:  W S Pear; S Ingvarsson; D Steffen; M Münke; U Francke; H Bazin; G Klein; J Sümegi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

10.  The 5T2 mouse multiple myeloma model: characterization of 5T2 cells within the bone marrow.

Authors:  J W Croese; C M Vas Nunes; J Radl; M H van den Enden-Vieveen; R J Brondijk; W J Boersma
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

View more
  3 in total

1.  Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4.

Authors:  Leonardo Mirandola; Yuefei Yu; Marjorie R Jenkins; Raffaella Chiaramonte; Everardo Cobos; Constance M John; Maurizio Chiriva-Internati
Journal:  BMC Cancer       Date:  2011-09-16       Impact factor: 4.430

2.  Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions.

Authors:  W F Davidson; T Giese; T N Fredrickson
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

3.  Multiple myeloma: the (r)evolution of current therapy and a glance into future.

Authors:  Annamaria Gulla; Kenneth C Anderson
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.